Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
57.30
0.00 (0.00%)
At close: Mar 24, 2026
17.66% (1Y)
| Market Cap | 6.15B +24.8% |
| Revenue (ttm) | 9.52B +28.6% |
| Net Income | 537.75M +28.4% |
| EPS | 4.99 +27.6% |
| Shares Out | 107.42M |
| PE Ratio | 11.49 |
| Forward PE | n/a |
| Dividend | 1.40 (2.41%) |
| Ex-Dividend Date | Nov 20, 2025 |
| Volume | 154,183 |
| Average Volume | 350,248 |
| Open | 58.00 |
| Previous Close | n/a |
| Day's Range | 56.70 - 58.70 |
| 52-Week Range | 45.50 - 65.80 |
| Beta | -0.03 |
| RSI | 46.64 |
| Earnings Date | Jan 28, 2026 |